Increased Risk of Tourette Syndrome with Leukotriene Modifier Use in Children with Allergic Diseases and Asthma: A Nationwide Population-Based Study

• Váldodahkkit: Min-Lan Tsai (Dahkki), Hsiu-Chen Lin (Dahkki), Chiung-Hui Yen (Dahkki), Jung-Tzu Ku (Dahkki), Shian-Ying Sung (Dahkki), Hsi Chang (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: MDPI AG, 2022-10-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

(1) Background: Cysteinyl leukotriene receptor antagonists (LTRAs), including montelukast and zafirlukast, are FDA-approved for treating pediatric asthma and allergic diseases. Tourette syndrome (TS), a common neuropsychiatric disorder in children, is associated with allergic diseases and asthma. In...